About this trial
Emergency hernia repairs are associated with significantly higher morbidity and mortality compared with elective hernia surgery. In Finland, approximately 500 emergency groin hernia repairs and 600 ventral hernia repairs are performed annually, but treatment practices vary widely, and high-quality evidence is lacking.
This prospective multicenter cohort study will evaluate outcomes of emergency groin and ventral hernia repairs in Finland. About 600 patients will be recruited over two years and followed for five years postoperatively. The study will collect standardized data on patient demographics, comorbidities, surgical technique, intraoperative findings, postoperative course, and long-term follow-up. Quality of life will be assessed with RAND-36, AAS, and PROMIS questionnaires.
The primary endpoint is hernia recurrence within two years after surgery. Secondary outcomes include 30- and 90-day complications, infection rates, readmissions, recovery time, and quality of life at 1, 2, and 5 years.
The results will provide robust evidence to guide clinical practice, optimize surgical techniques, and refine urgency classification and surgeon competence requirements for emergency hernia repair.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Emergency repair of a groin or ventral hernia
Disqualifiers
Pregnancy
Age under 18 years
Advanced malignancy
Inability to follow up (e.g., long travel distance or poor functional status)
Trial population
Patients, who will undergo emergency ventral or inguinal hernia repair between Oct 1st 2025 and Sep 31st 2027 in participating hospitals
Trial design
Cohort
Prospective
Treatments tested in this trial
Emergency hernia repair
Procedure/SurgeryPatients who will have either their ventral or inguinal hernia repaired in emergency surgery. The techniques are not standardized, but the details will be collected to prospective database.
Treatment groups
Trial outcomes
Primary outcomes
Number of patients with hernia recurrence
Either clinical or radiological recurrent hernia * Risk of recurrence and quality of life at 1, 2, and 5 years * Impact of wound and mesh infections, as well as other postoperative factors, on recurrence * Effectiveness and safety of different surgical techniques
Secondary outcomes
Surgical site infection rate 30 days after surgery
Surgical site infection as described by Centers for Disease Control and Prevention
Incidence of Postoperative complications 30 after the surgery
Surgical complications graded by Clavien-Dindo Classification
Number of patients who died 30 days after the surgery
Death after the surgery
Incidence of hernia related re-operations during the 5 years' follow-up
Reoperations due to recurrent hernia, mesh or other operations at the previous hernia site
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: